| Metric | შპს ნეოლაბი | შპს თბილისის ცენტრალური ლაბორატორია |
|---|---|---|
| Growth | ||
| Revenue | ₾2.3m₾1.9m | ₾3.0m₾3.1m |
| Revenue growth | 21.5% | -3.3% |
| Profitability | ||
| EBITDA | -₾632k-₾787k | ₾318k₾511k |
| EBITDA margin | -26.9%-40.8% | 10.6%16.5% |
| Net profit | -₾643k-₾834k | ₾316k₾503k |
| Net margin | -27.4%-43.2% | 10.5%16.2% |
| Balance sheet | ||
| Total assets | ₾6.3m₾7.9m | ₾926k₾980k |
| Total equity | ₾6.2m₾7.7m | ₾267k₾551k |
| ROE | -10.4%-10.8% | 118.4%91.3% |